Citation Impact
Citing Papers
The Degradation of Human Endothelial Cell-derived Perlecan and Release of Bound Basic Fibroblast Growth Factor by Stromelysin, Collagenase, Plasmin, and Heparanases
1996
Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels
1998 Standout
Matrix metalloproteinases and the regulation of tissue remodelling
2007 Standout
The role of tissue factor in the antiphospholipid syndrome
2001
Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice
2001 StandoutNobel
Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): A critical player in the development of atherosclerosis and related disorders
2005 Standout
Vitamin C as an Antioxidant: Evaluation of Its Role in Disease Prevention
2003 Standout
Exercise Standards for Testing and Training
2013 Standout
Low-density lipoproteins inhibit histamine and NaNO2 relaxations of the coronary vasculature and reduce contractile function in isolated rat hearts
1995
MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes
1998 Standout
The Hallmarks of Cancer
2000 Standout
3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.
1997 Standout
Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.
1995 Standout
The protective role of high‐density lipoprotein on oxidized‐low‐density‐lipoprotein‐induced U937/endothelial cell interactions
1994
Antioxidant enzymes and human diseases
1999 Standout
Zinc, Copper, and Magnesium and Risks for All-Cause, Cancer, and Cardiovascular Mortality
2006 Standout
Hyperlipidemic endothelial injury and angiogenesis
1994
A qualitative process system for modeling NF-κB and AP-1 gene regulation in immune cell biology research
1999 StandoutNobel
Antioxidants and Atherosclerotic Heart Disease
1997 Standout
Structure-antioxidant activity relationships of flavonoids and phenolic acids
1996 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
THE EFFECT OF HUMAN ENDOTHELIAL CELL‐DERIVED PROTEOGLYCANS ON HUMAN SMOOTH MUSCLE CELL GROWTH
1997
The Antiphospholipid Syndrome
2002 Standout
Resveratrol: A molecule whose time has come? And gone?
1997 Standout
Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B
1993
Cholesterol Reduction in Cardiovascular Disease — Clinical Benefits and Possible Mechanisms
1995
Designing hydrogels for controlled drug delivery
2016 Standout
Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro.
1994
Tissue Factor Pathway and the Antiphospholipid Syndrome
2000
Melatonin as a natural ally against oxidative stress: a physicochemical examination
2011 Standout
Mechanism of the Tumor Necrosis Factor α-mediated Induction of Endothelial Tissue Factor
1995
Heparin desulfation modulates VEGF release and angiogenesis in diabetic wounds
2015
FGF-2 and VEGF functionalization of starPEG–heparin hydrogels to modulate biomolecular and physical cues of angiogenesis
2010
Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection
2005 Standout
The role of oxidized lipoproteins in atherogenesis
1996
Dietary copper supplementation reduces atherosclerosis in the cholesterol-fed rabbit
1999
Endothelial Dysfunction and Coronary Risk Reduction
1998
Localization of distinct F2-isoprostanes in human atherosclerotic lesions.
1997
The possible role of copper ions in atherogenesis: the Blue Janus
1997
3D extracellular matrix interactions modulate tumour cell growth, invasion and angiogenesis in engineered tumour microenvironments
2016
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Multifunctional silk–heparin biomaterials for vascular tissue engineering applications
2013
Homocysteine and Atherothrombosis
1998 Standout
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Oxidative Stress: Harms and Benefits for Human Health
2017 Standout
The role of lipid peroxidation and antioxidants in oxidative modification of LDL
1992 Standout
Wound repair and regeneration: Mechanisms, signaling, and translation
2014 Standout
Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes.
1994
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Oxidation of LDL to a biologically active form by derivatives of nitric oxide and nitrite in the absence of superoxide. Dependence on pH and oxygen.
1994 StandoutNobel
Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro.
1993
Advances in engineering hydrogels
2017 StandoutScience
Both Intracellular and Extracellular Vitamin C Inhibit Atherogenic Modification of LDL by Human Vascular Endothelial Cells
1997
Antioxidant properties of phenolic compounds
1997 Standout
Medical Perspective Antiphospholipid Antibodies, Thrombosis and Atherosclerosis in Systemic Lupus Erythematosus: a Unifying 'Membrane Stress Syndrome' Hypothesis
1994
Antioxidant Capacity As Influenced by Total Phenolic and Anthocyanin Content, Maturity, and Variety ofVacciniumSpecies
1998 Standout
Atherosclerosis: Basic Mechanisms
1995 Standout
Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs. An LDL receptor-independent phenomenon.
1993
Regulation of endothelial cell tissue factor expression by minimally oxidized LDL and lipopolysaccharide.
1993
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Paraoxonase and Atherosclerosis
2001 Standout
Update on Uses and Properties of Citrus Flavonoids: New Findings in Anticancer, Cardiovascular, and Anti-inflammatory Activity
2008 Standout
Oxidants and antioxidants in atherogenesis: an appraisal
1999
Derivation and characterization of glycoinositol-phospholipid anchor-defective human K562 cell clones.
1992
A chemical approach to unraveling the biological function of the glycosylphosphatidylinositol anchor
2007 StandoutNobel
Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases
2003 Standout
Antioxidant Capacity, Vitamin C, Phenolics, and Anthocyanins after Fresh Storage of Small Fruits
1999 Standout
MATRIX PROTEOGLYCANS: From Molecular Design to Cellular Function
1998 Standout
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells.
1993
Expression of very low density lipoprotein receptor in the vascular wall. Analysis of human tissues by in situ hybridization and immunohistochemistry.
1996 StandoutNobel
The Biomedical Use of Silk: Past, Present, Future
2018 Standout
Works of John R. Weis being referenced
Improved method of human umbilical arterial endothelial cell culture
1991
Oxidized low‐density lipoprotein increases cultured human endothelial cell tissue factor activity and reduces protein C activation 1
1991